Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2019 | Innovations in the clinical assessment of CLL

Carol Moreno • 20 Sep 2019
iwCLL 2019
Chronic Lymphocytic Leukemia Leukemia

Carol Moreno, MD, PhD, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, discusses clinical assessment of chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

More from Carol Moreno

1:53
MRD assessment in the era of novel therapies for CLL
Carol Moreno • 21 Sep 2019
Ibrutinib combinations for CLL: iLLUMINATE results & more
Carol Moreno • 15 Jan 2019

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals